Check Bone Biologics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.8M
EPS (TTM)
-4.02
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-825.0K
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
15109100.00%
Compare market cap, revenue, PE, and other key metrics of Bone Biologics Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $3.8M | NA | NA | 0.00% | |
BUY | $146.0B | 155.98% | 58.63 | 13.55% | |
BUY | $144.1B | 82.61% | 49.98 | 12.25% | |
BUY | $233.5B | 24.24% | 16.83 | 32.43% | |
BUY | $121.3B | -12.46% | 26.13 | 13.63% |
The Bone Biologics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bone Biologics Corp investment value today
Current value as on today
₹21,940
Returns
Returns from Bone Biologics Corp Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Bone Biologics Corp. Average target price of $22.5
Get share price movements and forecasts by analysts on Bone Biologics Corp.
What analysts predicted
90.58%UPSIDE
Target Price
$22.5
Current Price
$2.12
Analyzed by
7 Analysts
Target
$22.50
Bone Biologics Corp target price $22.5, a slight upside of 90.58% compared to current price of $2.12. According to 7 analysts rating.
Investment in Bone Biologics Corp Shares on INDmoney has grown by 912.50% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:912.50% versus previous 30 day period
Search interest for Bone Biologics Corp Stock has increased by 1020% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1020% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Boston Scientific Corp. has given 19.3% return, outperforming this stock by 102.4%
Against Peers
In the last 3 years, Boston Scientific Corp. has given 136.2% return, outperforming this stock by 236.1%
Price Dip
In the last 3 months, BBLG stock has moved down by -60.2%
Organisation | Bone Biologics Corp |
Headquarters | 2 Burlington Woods Drive, Burlington, MA, United States, 01803 |
Industry | Biotechnology |
CEO | Mr. Jeffrey Frelick |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Jeffrey Frelick | CEO & President |
Ms. Deina H. Walsh CPA | Chief Financial Officer |
Bone Biologics Corp share price today is $2.12 as on at the close of the market. Bone Biologics Corp share today touched a day high of $2.15 and a low of $2.08.
Bone Biologics Corp share touched a 52 week high of $16.5 on and a 52 week low of $1.95 on . Bone Biologics Corp stock price today i.e. is closed at $2.12,which is 87.15% down from its 52 week high and 8.71% up from its 52 week low.
Bone Biologics Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Bone Biologics Corp (BBLG) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Bone Biologics Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bone Biologics Corp share’s latest price of $2.12 as on September 18, 2025 at 1:29 am IST, you will get 4.7170 shares of Bone Biologics Corp. Learn more about
fractional shares .